Squar Milner Financial Services’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-50
Closed -$3K 397
2020
Q1
$3K Hold
50
﹤0.01% 641
2019
Q4
$3K Buy
+50
New +$3.26K ﹤0.01% 692
2019
Q3
Sell
-1,507
Closed -$102K 403
2019
Q2
$102K Sell
1,507
-2,400
-61% -$158K 0.07% 274
2019
Q1
$253K Buy
3,907
+1,200
+44% +$79.8K 0.19% 129
2018
Q4
$169K Buy
2,707
+2,700
+38,571% +$189K 0.16% 154
2018
Q3
$1K Hold
7
﹤0.01% 741
2018
Q2
$0 Buy
+7
New +$494 ﹤0.01% 842

Other funds holding GILD

Squar Milner Financial Services's GILD Position: Q2 2020 in Review

Squar Milner Financial Services sold out of Gilead Sciences (GILD) in Q2 2020, closing a stake of 50 shares — an estimated $3K sold.

Squar Milner Financial Services first reported a position in GILD in Q2 2018 and held it in 7 quarters. The position peaked at $253K in Q1 2019. 1,626 funds tracked by Wall St. Rank hold GILD as of Q2 2020.

  • Squar Milner Financial Services reported no remaining Gilead Sciences position as of Q2 2020 after selling out during the quarter.
  • Squar Milner Financial Services sold 50 Gilead Sciences shares in Q2 2020, an estimated $3K.
  • Squar Milner Financial Services first reported a position in Gilead Sciences in Q2 2018 and held it in 7 quarters.
  • Squar Milner Financial Services's Gilead Sciences position peaked at $253K in Q1 2019.
  • 1,626 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2020.

Based on Squar Milner Financial Services's 13F filing for Q2 2020, filed 16 Jul 2020.